Eurofins: record sales for first nine months

(CercleFinance.com) - Eurofins Scientific has unveiled record sales for the first nine months of the year, up 2.
7% to 5.03 billion euros, with strong organic growth and acquisitions more than compensating for a decline in Covid-19-related revenue.

The French bioanalytical services giant specifies that its core business (outside Covid-19) has achieved organic growth of 6.7% for the third quarter (excluding calendar effects), surpassing its mid-term targets (+6.5% per year).

Eurofins confirmed its 2022 targets and plans to update those for 2023 and 2024 when it publishes its 2022 annual accounts, expecting to gain more clarity by then with regard to the war in Ukraine, supply issues and inflation.

Copyright (c) 2022 CercleFinance.com. All rights reserved.